pyrazolanthrone has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, R; Han, Y; Huang, S; Li, M; Li, W; Ma, C; Mao, Z; Shi, L; Su, X; Wang, W; Xie, Y; Zhu, Z | 1 |
1 other study(ies) available for pyrazolanthrone and MPTP Neurotoxicity Syndrome
Article | Year |
---|---|
SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anthracenes; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; JNK Mitogen-Activated Protein Kinases; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; MPTP Poisoning; Neurons | 2004 |